EVs were shown to transfer Src homology 2 (SH2)-containing protein tyrosine phosphatase 2 (SHP2), both transcript and protein, from B16F0 melanoma cells to primary CD8+ T cells, thus inhibiting T cell viability [72]. Here, CD8A is linked to melanoma.